Fidelity Global Healthcare Y-Dis-EUR
Healthcare and BiotechnologyPricing frequency
Daily
Dealing cut off time
13:45
Type
SICAV
Yield
0.04%
NAV
€34.86
Income frequency
Annually
Ongoing charge
1.05%
Latest actual NAV date
16-11-2026
ISIN
LU0936578961
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Eli Lilly and Co | 9.06 |
| Johnson & Johnson | 8.16 |
| AbbVie Inc | 7.81 |
| Roche Holding AG Ordinary Shares new | 6.54 |
| UnitedHealth Group Inc | 6.50 |
| AstraZeneca PLC | 4.78 |
| Thermo Fisher Scientific Inc | 4.70 |
| Stryker Corp | 4.07 |
| Gilead Sciences Inc | 3.63 |
| Bayer AG | 3.06 |
Investment objective
The fund aims to achieve capital growth over the long term. The fund invests at least 70% of its assets in equities of companies from anywhere in the world. The fund aims to make investments in companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.